Michael Wang
Duke University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Lymphoma Diagnosis and Treatment
Strong evidence · 3 supporting papers · latest 2026
Chronic Lymphocytic Leukemia Research
Solid evidence · 1 supporting paper · latest 2026
Cutaneous lymphoproliferative disorders research
Solid evidence · 2 supporting papers · latest 2026
Monoclonal and Polyclonal Antibodies Research
Supporting evidence · 1 supporting paper · latest 2026
CAR-T cell therapy research
Supporting evidence · 1 supporting paper · latest 2026
CNS Lymphoma Diagnosis and Treatment
Supporting evidence · 1 supporting paper · latest 2026
Publications (3)
Real World Outcomes and Predictive Factors of Pirtobrutinib in Mantle Cell Lymphoma After Failure of Covalent Bruton Tyrosine Kinase Inhibitors
2026DOI
ORAL ABSTRACT: CT-230: Outcomes of Lisocabtagene Maraleucel (Liso-Cel) in Patients With Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): First Real-World Data From the Center for International Blood and Marrow Transplant Research (CIBMTR)
2026DOI
CD70-Driven Immunosuppression in Mantle Cell Lymphoma Identifies a Vulnerability to CD70-Directed Bispecific Antibody Modalities
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Duke University
Source: ScienceWe Extractor · retrieved 2026-09-27